Denali Therapeutics Inc. Competitors
| Symbol | Company | Share Price | Market Cap | P/E Ratio | Employee Count | Revenue |
|---|---|---|---|---|---|---|
 AKRO
|
Akero Therapeutics, Inc. | $31.27 | $1.59 B | -7.1 | 60 | $0 |
 APLS
|
Apellis Pharmaceuticals, Inc. | $29.00 | $4.90 B | -11.77 | 702 | $396.59 M |
 ASND
|
Ascendis Pharma A/S | $123.96 | $7.77 B | -14.19 | 879 | $266.72 M |
 BCEL
|
Atreca, Inc. | $0.09 | $3.66 M | -0.04 | 90 | $770,000 |
 BDTX
|
Black Diamond Therapeutics, Inc. | $2.49 | $291.95 M | -3.13 | 54 | $0 |
 BGNE
|
BeiGene, Ltd. | $189.65 | $17.07 B | -20.76 | 10600 | $2.46 B |
 BPMC
|
Blueprint Medicines Corporation | $97.75 | $6.47 B | -21.48 | 638 | $249.38 M |
 CERE
|
Cerevel Therapeutics Holdings, Inc. | $44.96 | $7.29 B | -14.66 | 355 | $0 |
 DAWN
|
Day One Biopharmaceuticals, Inc. | $13.50 | $1.12 B | -5.11 | 174 | $0 |
 DSGN
|
Design Therapeutics, Inc. | $5.69 | $217.51 M | -3.7 | 54 | $0 |
 FDMT
|
4D Molecular Therapeutics, Inc. | $8.02 | $1.17 B | -9.63 | 147 | $20.72 M |
 FIXX
|
Homology Medicines, Inc. | $0.93 | $3.02 M | -0.03 | 7 | $1.16 M |
 GLUE
|
Monte Rosa Therapeutics, Inc. | $8.49 | $243.38 M | -1.59 | 133 | $0 |
 HOWL
|
Werewolf Therapeutics, Inc. | $1.86 | $151.66 M | -3.17 | 45 | $19.94 M |
 IKNA
|
Ikena Oncology, Inc. | $1.72 | $84.45 M | -1.11 | 14 | $9.16 M |
 LEGN
|
Legend Biotech Corporation | $39.75 | $8.31 B | -17.66 | 2400 | $285.14 M |
 PCVX
|
Vaxcyte, Inc. | $89.48 | $7.72 B | -16.54 | 254 | $0 |
 RNA
|
Avidity Biosciences, Inc. | $43.13 | $2.54 B | -8.99 | 253 | $9.56 M |
 RVMD
|
Revolution Medicines, Inc. | $56.98 | $6.66 B | -10.51 | 490 | $11.58 M |
 STOK
|
Stoke Therapeutics, Inc. | $11.25 | $774.50 M | -6.14 | 110 | $8.78 M |
 SWTX
|
SpringWorks Therapeutics, Inc. | $37.42 | $2.98 B | -7.81 | 305 | $5.45 M |
 TVTX
|
Travere Therapeutics, Inc. | $18.37 | $542.80 M | -1.32 | 380 | $145.24 M |